We’ve been bracing for weeks to gauge the impact of the COVID-19 outbreak on the way we eat. The numbers are finally coming in, and the National Restaurant Association is indicating 3 million jobs have been cut from its members’ payrolls since March 1. At least half of all establishments will lay off more people […]
People are talking about a recession forcing more states to accelerate their cannabis legalization efforts. I don’t really see it happening yet, but it’s nice to see the stocks rebounding now. My guess is that these stocks were simply oversold, and the short sellers are covering their positions. Whether that’s an illusion or a sign […]
This week has been welcome relief for investors who are still struggling to digest a month in which 97% of the stocks in the S&P 500 are down and the market as a whole has dropped 25% from its peak. The aggregate numbers are daunting. Every sector has at least suffered a 10% correction, and […]
While every jurisdiction is different, most are considering non-medicinal cannabis sales non-essential. That changes the sales landscape a lot. At this point, I would avoid all but the biggest cultivators. Smaller farms will get squeezed here because they lack the scale to compete with the giants and the resources to survive a slow season. Ultimately, […]
Wall Street has finally calmed down a little in the last few days as lenders relax repayment rules on what could soon become millions of newly unemployed workers. Volatility has finally receded. I suspect that this is only the calm between the storms, or the eye of the coronavirus hurricane if you prefer. The S&P […]
I warned you last week that cash is now king in Big Cannabis. Narratives that once revolved around projecting growth curves to the sky are now focused on making sure there’s enough money on the balance sheet to make it to breakeven. Tilray Corp. (NASDAQ:TLRY) will probably need until late 2021 (in the best case […]